Efficacy and Safety of Subcutaneous Pertuzumab–Trastuzumab (Phesgo) in Neoadjuvant Treatment of HER2-positive Breast Cancer: Real-world Data from Japan
Anticancer Research · 2026-01 · 46 (1) · 293-300
DOI: 10.21873/anticanres.17943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 30.12.2025. Verfasst von Haruhito Kinoshita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Trastuzumab, Erb-b2 Receptor Tyrosine Kinases, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; spqv9ke9@view.ocn.ne.jp.
- Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Zitieren
APA
Kinoshita, H., Kashiwagi, S., Nishikawa, M., Watanabe, C., Takada, K., Tauchi, Y., Ogisawa, K., Shibutani, M., & Morisaki, T. (2026). Efficacy and Safety of Subcutaneous Pertuzumab–Trastuzumab (Phesgo) in Neoadjuvant Treatment of HER2-positive Breast Cancer: Real-world Data from Japan. Anticancer Research, 46(1), 293-300. https://doi.org/10.21873/anticanres.17943
Vancouver
Kinoshita H, Kashiwagi S, Nishikawa M, Watanabe C, Takada K, Tauchi Y, et al. Efficacy and Safety of Subcutaneous Pertuzumab–Trastuzumab (Phesgo) in Neoadjuvant Treatment of HER2-positive Breast Cancer: Real-world Data from Japan. Anticancer Research. 2026;46(1):293-300. doi:10.21873/anticanres.17943
BibTeX
@article{Kinoshita2026,
author = {Kinoshita, Haruhito and Kashiwagi, Shinichiro and Nishikawa, Mariko and Watanabe, Chika and Takada, Koji and Tauchi, Yukie and Ogisawa, Kana and Shibutani, Masatsune and Morisaki, Tamami},
title = {Efficacy and Safety of Subcutaneous Pertuzumab–Trastuzumab (Phesgo) in Neoadjuvant Treatment of HER2-positive Breast Cancer: Real-world Data from Japan},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {1},
pages = {293--300},
doi = {10.21873/anticanres.17943}
}
EUVIMED